Literature DB >> 31439224

Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles.

Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Lixia Jiao, Jean-Claude Tardif, John Gregson, Stuart J Pocock, Christie M Ballantyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31439224     DOI： 10.1016/j.jacc.2019.06.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  15 in total

1.  Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.

Authors:  Robert C Block; Gregory C Shearer; Ashley Holub; Xin M Tu; Shaker Mousa; J Thomas Brenna; William S Harris; Nathan Tintle
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-04-24       Impact factor: 3.015

Review 2.  Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.

Authors:  William E Boden; Deepak L Bhatt; Peter P Toth; Kausik K Ray; M John Chapman; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

3.  Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007-2014.

Authors:  Wenjun Fan; Sephy Philip; Craig Granowitz; Peter P Toth; Nathan D Wong
Journal:  Cardiol Ther       Date:  2020-04-23

Review 4.  Targeting multiple domains of residual cardiovascular disease risk in patients with diabetes.

Authors:  Kershaw V Patel; Muthiah Vaduganathan
Journal:  Curr Opin Cardiol       Date:  2020-09       Impact factor: 2.161

Review 5.  Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

Authors:  Jean-Charles Fruchart; Michel P Hermans; Jamila Fruchart-Najib
Journal:  Curr Atheroscler Rep       Date:  2020-07-15       Impact factor: 5.113

Review 6.  Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models.

Authors:  Debapriya Basu; Karin E Bornfeldt
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-06       Impact factor: 5.555

7.  Bioprospecting for Antithrombotic Polar Lipids from Salmon, Herring, and Boarfish By-Products.

Authors:  Alexandros Tsoupras; Eoin O'Keeffe; Ronan Lordan; Shane Redfern; Ioannis Zabetakis
Journal:  Foods       Date:  2019-09-15

8.  Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Akira Sekikawa; Chendi Cui; Daisuke Sugiyama; Anthony Fabio; William S Harris; Xiao Zhang
Journal:  Nutrients       Date:  2019-10-30       Impact factor: 5.717

9.  Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid.

Authors:  R Preston Mason; Peter Libby; Deepak L Bhatt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-26       Impact factor: 8.311

10.  Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases.

Authors:  Sébastien Gaertner; Cyril Auger; Muhammad A Farooq; Brigitte Pollet; Sonia Khemais-Benkhiat; Zahid R Niazi; Sophie Schrevens; Sin-Hee Park; Florence Toti; Dominique Stephan; Valérie B Schini-Kerth
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.